Current Report Filing (8-k)
October 20 2020 - 4:59PM
Edgar (US Regulatory)
Ingevity Corp false 0001653477 0001653477 2020-10-20 2020-10-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d)
of the Securities Exchange Act of 1934
October 20, 2020
Date of Report (date of earliest event reported)
INGEVITY CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-37586
|
|
47-4027764
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
4920 O’Hear Avenue Suite 400
|
|
North Charleston
|
|
South Carolina
|
|
29405
|
|
(Address of principal executive offices)
|
|
(Zip code)
|
Registrant’s telephone number, including area code: 843-740-2300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
Common Stock ($0.01 par value)
|
|
NGVT
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
ITEM 8.01. OTHER EVENTS
In a press release issued on October 20, 2020, Ingevity Corporation (“Ingevity”) announced the pricing of its previously announced private offering of $550 million in aggregate principal amount of senior unsecured notes due 2028. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
INGEVITY CORPORATION
(Registrant)
|
|
|
|
|
|
|
|
By:
|
|
/S/ JOHN C. FORTSON
|
|
|
|
|
|
John C. Fortson
|
|
|
|
|
|
President and Chief Executive Officer
|
|
Date: October 20, 2020
|
|
|
|
|
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ingevity (NYSE:NGVT)
Historical Stock Chart
From Apr 2023 to Apr 2024
